Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway

ACS Medicinal Chemistry Letters

Volumn 1, Issue 9, 2010, Pages 454-459

  Ren, Xiaomei ^a,b   Duan, Lei ^a   He, Qiang ^a   Zhang, Zhang ^a   Zhou, Yi ^a   Wu, Donghai ^a   Pan, Jingxuan ^b   Pei, Duanqing ^a   Ding, Ke ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

apoptosis; cell cycle arrest; inhibitor; niclosamide; STAT3 signaling pathway

Indexed keywords

ANTINEOPLASTIC AGENT; MOLECULAR SCAFFOLD; NICLOSAMIDE; SALICYLIC ACID; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL GROWTH; CONTROLLED STUDY; DRUG IDENTIFICATION; ENZYME ACTIVATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 78650210593     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml100146z     Document Type: Article

References (37)

1. Darnell, J. E., Jr. STATs and gene regulation Science 1997, 277, 1630-1635
2. Bromberg, J.; Darnell, J. E., Jr. The role of STATs in transcriptional control and their impact on cellular function Oncogene 2000, 19, 2468-2473
3. Bowman, T.; Garcia, R.; Turkson, J.; Jove, R. STATs in oncogenesis Oncogene 2000, 19, 2474-2488
4. Hirano, T.; Ishihara, K.; Hibi, N. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors Oncogene 2000, 19, 2548-2556
5. Yu, H.; Kortylewski, M.; Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Nat. Rev. Immunol. 2007, 7, 41-51
6. Yu, H.; Jove, R. The STATs of cancer-New molecular targets come of age Nat. Rev. Cancer 2004, 4, 97-105
7. Darnell, J. E., Jr. Transcription factors as targets for cancer therapy Nat. Rev. Cancer 2002, 2, 740-749
8. Turkson, J.; Jove, R. STAT proteins: novel molecular targets for cancer drug discovery Oncogene 2000, 19, 6613-6626
9. Deng, J.; Grande, F.; Neamati, N. Small molecule inhibitors of stat3 signaling pathway Curr. Cancer Drug Targets 2007, 7, 91-107
10. Germain, D.; Frank, D. A. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy Clin. Cancer Res. 2007, 13, 5665-5669
11. Costantino, L.; Barlocco, D. STAT 3 as a target for cancer drug discovery Curr. Med Chem. 2008, 15, 834-843
12. Fletcher, S.; Turkson, J.; Gunning, P. T. Molecular approaches towards the inhibition of the signal transducer and activator of transcription 3 (Stat3) protein ChemMedChem 2008, 3, 1159-1168
13. Maloney, K. N.; Hao, W.; Xu, J.; Gibbons, J.; Hucul, J.; Roll, D.; Brady, S. F.; Schroeder, F. C.; Clardy, J. Phaeosphaeride A, an inhibitor of STAT3-dependent signaling isolated from an endophytic fungus Org. Lett. 2006, 8, 4067-4070
14. Shin, D. S.; Kim, H.-N.; Shin, K. D.; Yoon, Y. J.; Kim, S.-J.; Han, D. C.; Kwon, B.-M. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells Cancer Res. 2009, 69, 193-202
15. Sun, J.; Blaskovich, M. A.; Jove, R.; Livingston, S. K.; Coppola, D.; Sebti, S. M. Cucurbitacin Q: A selective STAT3 activation inhibitor with potent antitumor activity Oncogene 2005, 24, 3236-3245
16. For selected examples of peptidic or peptide mimic inhibitors, see Chen, J.; Nikolosha-Coleska, Z.; Yang, C.-Y.; Gomez, C.; Gao, W.; Krajewski, K.; Jiang, S.; Roller, P.; Wang, S. Design and synthesis of a new, conformationally constrained, macrocyclic small-molecule inhibitor of STAT3 via 'click chemistry' Bioorg. Med. Chem. Lett. 2007, 17, 3939-3942
17. Gomez, C.; Bai, L.; Zhang, J.; Nikolovska-Coleska, Z.; Chen, J.; Yi, H.; Wang, S. Design, synthesis, and evaluation of peptidomimetics containing Freidinger lactams as STAT3 inhibitors Bioorg. Med. Chem. Lett. 2009, 19, 1733-1736
18. Coleman, D. R.; Ren, Z.; Mandal, P. K.; Cameron, A. G.; Dyer, G. A.; Muranjan, S.; Campbell, M.; Chen, X.; McMurray, J. S. Investigation of the binding determinants of phosphopeptides targeted to the Src homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor J. Med. Chem. 2005, 48, 6661-6670
19. Siddiquee, K. A. Z.; Gunning, P. T.; Glenn, M.; Katt, W. P.; Zhang, S.; Schroeck, C.; Sebti, S. M.; Jove, R.; Hamilton, A. D.; Turkson, J. An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects ACS Chem. Biol. 2007, 2, 787-798
20. Gunning, P. T.; Glenn, M.; Siddiquee, K. A. Z.; Katt, W. P.; Masson, E.; Sebti, S. M.; Turkson, J.; Hamilton, A. D. Targeting protein-protein interactions: Suppression of Stat3 dimerization with rationally designed small-molecule, nonpeptidic SH2 domain binders ChemBioChem 2008, 9, 2800-2803
21. Mandal, P. K.; Limbrick, D.; Coleman, D. R.; Dyer, G. A., IV; Ren, Z.; Birtwistle, J. S.; Xiong, C.; Chen, X.; Briggs, J. M.; McMurray, J. S. Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription 3: Evaluation and molecular modeling J. Med. Chem. 2009, 52, 2429-2442
22. Mandal, P. K.; Ren, Z.; Chen, X.; Xiong, C.; McMurray, J. S. Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3 J. Med. Chem. 2009, 52, 6126-6141
23. Timofeeva, O. A.; Gaponenko, V.; Lockett, S. J.; Tarasov, S. G.; Jiang, S.; Michejda, C. J.; Perantoni, A. O.; Tarasova, N. I. Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target ACS Chem. Biol. 2007, 2, 799-809
24. Mandal, P. K.; Liao, W. S.-L.; McMurray, J. S. Syhthesis of phosphatase-stable cell-permeable peptidomimetic prodrugs that target the SH2 domain of Stat3 Org. Lett. 2009, 11, 3394-3397
25. Chen, J.; Bai, L.; Bernard, D.; Nikolovska-Coleska, Z.; Gomez, C.; Zhang, J.; Yi, H.; Wang, S. Structure-based design of conformationally constrained cell-permeable STAT3 inhibitors ASC Med. Chem Lett. 2010, 1, 85-89
26. Song, H.; Wang, R.; Wang, S.; Lin, J. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 4700-4705
27. Siddiquee, K.; Zhang, S.; Guide, W. C.; Blaskovich, M. A.; Greedy, B.; Lawrence, H. R.; Yip, M. L. R.; Jove, R.; McLaughlin, M. M.; Lawrence, N. J.; Sebti, S. M.; Turkson, J. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 7391-7396
28. Schust, J.; Sperl, B.; Hollis, A.; Mayer, T. U.; Berg, T. Stattic: A small-molecule inhibitor of STAT3 activation and dimerization Chem. Biol. 2006, 13, 1235-1242
29. Kim, B. H.; Yin, C.-H.; Guo, Q.; Bach, E. A.; Lee, H.; Sandoval, C.; Jayabose, S.; Ulaczyk-Lesanko, A.; Hall, D. G.; Baeg, G.-H. A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells Mol. Cancer Ther. 2008, 7, 2672-2680
30. Xu, J.; Cole, D. C.; Chang, C.-P. B.; Ayyad, R.; Assalin, M.; Hao, W.; Gibbons, J.; Jelinsky, S. A.; Saraf, K. A.; Park, K. Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-Oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid esters J. Med. Chem. 2008, 51, 4115-4121
31. Xu, X.; Kasembeli, M. M.; Jiang, X.; Tweardy, B. J.; Tweardy, D. J. Chemical probes that competitively and selectively inhibit Stat3 activation PLoS ONE 2009, 4, e4783
32. Zhang, X.; Yue, P.; Fletcher, S.; Zhao, W.; Gunning, P. T.; Turkson, J. A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interaction and Stat3-dependent tumor process Biochem. Pharmacol. 2010, 79, 1398-1409
33. Fletcher, S.; Singh, J.; Zhang, X.; Yue, P.; Page, B. D.; Sharmeen, S.; Zhao, M.; Schimmer, A. D.; Turkson, J.; Gunning, P. T. Disruption of transcriptionally active State dimmers with non-phosphorylated, salicylic acid-based small molecules: potent in vitro and tumor cell activities ChemBiochem 2009, 10, 1959-1964
34. Matsuno, K.; Masuda, Y.; Uehara, Y.; Sato, H.; Muroya, A.; Takahashi, O.; Yokotagawa, T.; Furuya, T.; Okawara, T.; Otsuka, M.; Ogo, N.; Ashizawa, T.; Oshita, C.; Tai, S.; Ishii, H.; Akiyama, Y.; Asai, A. Identification of a New Series of STAT3 Inhibitors by Virtual Screening. ACS Med. Chem. Lett. 2010, DOI: 10.1021/ml1000273.
35. Chong, C. R.; Sullivan, D. J. New uses for old drugs Nature 2007, 448, 645-646
36. Ashburn, T. T.; Thor, K. B. Drug repositioning: Identifying and developing new uses for existing drugs Nat. Rev. Drug Discovery 2004, 3, 673-683
37. Schust, J.; Berg, T. A high-throughput assay for signal transducer and activator of transcription 3 Anal. Biochem. 2004, 330, 114-118